Attenuated stress response to acute restraint and forced swimming stress in arginine vasopressin 1b receptor subtype (Avpr1b) receptor knockout mice and wild-type mice treated with a novel Avpr1b receptor antagonist

Journal of Neuroendocrinology

Volumn 22, Issue 11, 2010, Pages 1173-1180

  Roper, J A ^a   Craighead, M ^b   O'Carroll, A M ^a   Lolait, S J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b MSD   (United Kingdom)

Author keywords

Acute stress; Avpr1b receptor antagonist; Hypothalamic pituitary adrenal axis; Vasopressin

Indexed keywords

ARGIPRESSIN RECEPTOR; ARGIPRESSIN RECEPTOR 1B; ARGIPRESSIN RECEPTOR 1B ANTAGONIST ORG; CORTICOSTERONE; CORTICOTROPIN; HORMONE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ACUTE STRESS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; FEMALE; FORCED SWIMMING TEST; HORMONE DETERMINATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; HANDLING (PSYCHOLOGY); HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PITUITARY-ADRENAL SYSTEM; RECEPTORS, VASOPRESSIN; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 77958549524     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2010.02070.x     Document Type: Article

References (58)

1. Antoni FA. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 1993; 14: 76-122.
2. Koshimizu TA, Nasa Y, Tanoue A, Oikawa R, Kawahara Y, Kiyono Y, Adachi T, Tanaka T, Kuwaki T, Mori T, Takeo S, Okamura H, Tsujimoto G. V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity. Proc Natl Acad Sci USA 2006; 103: 7807-7812.
3. Bielsky IF, Hu S-B, Szegda KL, Westphal H, Young LJ. Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice. Neuropsychopharmacology 2004; 29: 483-493.
4. Winslow JT, Insel TR. Neuroendocrine basis of social recognition. Curr Opin Neurobiol 2004; 14: 248-253.
5. Li J-D, Burton KJ, Zhang C, Hu S-B, Zhou Q-Y. Vasopressin receptor V1a regulates circadian rhythms of locomotor activity and expression of clock-controlled genes in the suprachiasmatic nuclei. Am J Physiol Regul Integr Comp Physiol 2009; 296: R824-R830.
6. Egashira N, Mishima K, Iwasaki K, Oishi R, Fujiwara M. New topics in vasopressin receptors and approach to novel drugs: role of the vasopressin receptor in psychological and cognitive functions. J Pharmacol Sci 2009; 109: 44-49.
7. Knepper MA. Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin. Am J Physiol 1997; 272: F3-F12.
8. Herman JP, Prewitt CM, Cullinan WE. Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis. Crit Rev Neurobiol 1996; 10: 371-394.
9. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, Cullinan WE. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 2003; 24: 151-180.
10. Pacák K, Palkovits M. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocr Rev 2001; 22: 502-548.
11. Engelmann M, Landgraf R, Wotjak CT. The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited. Front Neuroendocrinol 2004; 25: 132-149.
12. Albeck DS, Hastings NB, McEwen BS. Effects of adrenalectomy and type I or type II glucocorticoid receptor activation on AVP and CRH mRNA in the rat hypothalamus. Mol Brain Res 1994; 26: 129-134.
13. Whitnall MH. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol 1993; 40: 573-629.
14. Serradeil-Le Gal C, Wagnon J, Simiand J, Griebel G, Lacour C, Guillon G, Barberis C, Brossard G, Soubrié P, Nisato D, Pascal M, Pruss R, Scatton B, Maffrand J-P, Le Fur G. Characterization of (2S, 4R)-1-[5-chloro-1-[(2, 4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2, 3-dihydro-1H-indol-3-yl]-4-hydroxy-N, N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist. J Pharmacol Exp Ther 2002; 300: 1122-1130.
15. Derick S, Cheng L, Voirol M, Stoev S, Giacomini M, Wo N, Szeto H, Mimoun M, Andres M, Gaillard R, Guillon G, Manning M. [1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors. Endocrinology 2002; 143: 4655-4664.
16. Pena A, Murat B, Trueba M, Ventura M, Wo N, Szeto H, Cheng L, Stoev S, Guillon G, Manning M. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8. J Med Chem 2007; 50: 835-847.
17. Craighead M, Milne R, Campbell-Wan L, Watson L, Presland J, Thomson FJ, Marston HM, Macsweeney CP. Characterization of a novel and selective V1B receptor antagonist. Prog Brain Res 2008; 170: 527-535.
18. Wersinger S, Ginns E, O'Carroll AM, Lolait SJ, Young WS. Vasopressin V1b receptor knockout reduces aggressive behavior in male mice. Mol Psychiatry 2002; 7: 975-984.
19. Tanoue A, Ito S, Honda K, Oshikawa S, Kitagawa Y, Koshimizu TA, Mori T, Tsujimoto G. The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. J Clin Invest 2004; 113: 302-309.
20. Lolait SJ, Stewart LQ, Jessop DS, Young WS, O'Carroll AM. The hypothalamic-pituitary-adrenal axis response to stress in mice lacking functional vasopressin V1b receptors. Endocrinology 2007; 148: 849-856.
21. Lolait SJ, Stewart LQ, Roper JA, Harrison G, Jessop DS, Young WS, O'Carroll AM. Attenuated stress response to acute lipopolysaccharide challenge and ethanol administration in vasopressin V1b receptor knockout mice. J Neuroendocrinol 2007; 19: 543-551.
22. Stewart LQ, Roper JA, Young WS, O'Carroll AM, Lolait SJ. Pituitary-adrenal response to acute and repeated mild restraint, forced swim and change in environment stress in arginine vasopressin receptor 1b knockout mice. J Neuroendocrinol 2008; 20: 597-605.
23. Spiga F, Harrison L, Macsweeney C, Thomson F, Craighead M, Lightman SL. Effect of vasopressin 1b receptor blockade on the hypothalamic-pituitary-adrenal response of chronically stressed rats to a heterotypic stressor. J Endocrinol 2009; 200: 285-291.
24. Spiga F, Harrison L, Wood S, Knight D, Macsweeney C, Thomson F, Craighead M, Lightman SL. Blockade of the V1b receptor reduces ACTH, but not corticosterone, secretion induced by stress without effecting basal HPA axis activity. J Endocrinol 2009; 200: 273-283.
25. Stewart LQ, Roper JA, Young WS, O'Carroll AM, Lolait SJ. The role of the arginine vasopressin Avp1b receptor in the acute neuroendocrine action of antidepressants. Psychoneuroendocrinology 2008; 33: 405-415.
26. Zelena D, Földes A, Mergl Z, Barna I, Kovács KJ, Makara GB. Effects of repeated restraint stress on hypothalamo-pituitary-adrenocortical function in vasopressin deficient Brattleboro rats. Brain Res Bull 2004; 63: 521-530.
27. Zelena D, Langnaese K, Domokos A, Pintér O, Landgraf R, Makara G, Engelmann M. Vasopressin administration into the PVN normalizes plasma oxytocin and corticosterone levels in Brattleboro rats. Endocrinology 2009; 150: 2791-2798.
28. Zelena D, Domokos A, Jain S, Jankord R, Filaretova L. The stimuli-specific role of vasopressin in the hypothalamo-pituitary-adrenal axis response to stress. J Endocrinol 2009; 202: 263-278.
29. Domokos A, Mergl Z, Barna I, Makara GB, Zelena D. Congenital vasopressin deficiency and acute and chronic opiate effects on hypothalamo-pituitary-adrenal axis activity in Brattleboro rats. J Endocrinol 2008; 196: 113-121.
30. Mlynarik M, Zelena D, Bagdy G, Makara GB, Jezova D. Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats. Horm Behav 2007; 51: 395-405.
31. Kjaer A, Knigge U, Bach FW, Warberg J. Impaired histamine- and stress-induced secretion of ACTH and beta-endorphin in vasopressin-deficient Brattleboro rats. Neuroendocrinology 1993; 57: 1035-1041.
32. Brudieux R, Krifi MN, Laulin JP. Release of aldosterone and corticosterone from the adrenal cortex of the Brattleboro rat in response to administration of ACTH. J Endocrinol 1986; 111: 375-381.
33. Eckland DJ, Todd K, Lightman SL. Immunoreactive vasopressin and oxytocin in hypothalamo-hypophysial portal blood of the Brattleboro and Long-Evans rat: effect of adrenalectomy and dexamethasone. J Endocrinol 1988; 117: 27-34.
34. Burgess WJ, Balment RJ. Plasma atrial natriuretic peptide in vasopressin deficiency: the effects of acute water deprivation in rats. J Endocrinol 1992; 135: 431-438.
35. Link H, Dayanithi G, Föhr KJ, Gratzl M. Oxytocin at physiological concentrations evokes adrenocorticotropin (ACTH) release from corticotrophs by increasing intracellular free calcium mobilized mainly from intracellular stores. Oxytocin displays synergistic or additive effects on ACTH-releasing factor or arginine vasopressin-induced ACTH secretion, respectively. Endocrinology 1992; 130: 2183-2191.
36. Schlosser SF, Almeida OF, Patchev VK, Yassouridis A, Elands J. Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type. Endocrinology 1994; 135: 2058-2063.
37. Nakamura K, Fujiwara Y, Mizutani R, Sanbe A, Miyauchi N, Hiroyama M, Yamauchi J, Yamashita T, Nakamura S, Mori T, Tsujimoto G, Tanoue A. Effects of vasopressin V1b receptor deficiency on adrenocorticotropin release from anterior pituitary cells in response to oxytocin stimulation. Endocrinology 2008; 149: 4883-4891.
38. Windle RJ, Shanks N, Lightman SL, Ingram CD. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 1997; 138: 2829-2834.
39. Yoshida M, Takayanagi Y, Inoue K, Kimura T, Young LJ, Onaka T, Nishimori K. Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J Neurosci 2009; 29: 2259-2271.
40. Ramos AT, Troncone LR, Tufik S. Suppression of adrenocorticotrophic hormone secretion by simultaneous antagonism of vasopressin 1b and CRH-1 receptors on three different stress models. Neuroendocrinology 2006; 84: 309-316.
41. Griffante C, Green A, Curcuruto O, Haslam C, Dickinson B, Arban R. Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist. Br J Pharmacol 2005; 146: 744-751.
42. Pena A, Murat B, Trueba M, Ventura MA, Bertrand G, Cheng LL, Stoev S, Szeto H, Wo N, Brossard G, Serradeil-Le Gal C, Manning M, Guillon G. Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptors. Endocrinology 2007; 148: 4136-4146.
43. Armario A, Restrepo C, Castellanos JM, Balasch J. Dissociation between adrenocorticotropin and corticosterone responses to restraint after previous chronic exposure to stress. Life Sci 1985; 36: 2085-2092.
44. Bhatnagar S, Sun LM, Raber J, Maren S, Julius D, Dallman M. Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor. Physiol Behav 2004; 81: 545-555.
45. Droste S, Chandramohan Y, Hill L, Linthorst AC, Reul JM. Voluntary exercise impacts on the rat hypothalamic-pituitary-adrenocortical axis mainly at the adrenal level. Neuroendocrinology 2007; 86: 26-37.
46. Bornstein SR, Engeland WC, Ehrhart-Bornstein M, Herman JP. Dissociation of ACTH and glucocorticoids. Trends Endocrinol Metab 2008; 19: 175-180.
47. Bornstein SR, Chrousos GP. Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J Clin Endocrinol Metab 1999; 84: 1729-1736.
48. Itoh S, Yamada S, Mori T, Miwa T, Tottori K, Uwahodo Y, Yamamura Y, Fukuda M, Yamamoto K, Tanoue A, Tsujimoto G. Attenuated stress-induced catecholamine release in mice lacking the vasopressin V1b receptor. Am J Physiol Endocrinol Metab 2006; 291: E147-E151.
49. Gallo-Payet N, Guillon G. Regulation of adrenocortical function by vasopressin. Horm Metab Res 1998; 30: 360-367.
50. Reyes TM, Walker JR, DeCino C, Hogenesch JB, Sawchenko PE. Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. J Neurosci 2003; 23: 5607-5616.
51. Young EA. Sex differences and the HPA axis: implications for psychiatric disease. Gend Specif Med 1998; 1: 21-27.
52. Uhart M, Chong RY, Oswald L, Lin P-I, Wand GS. Gender differences in hypothalamic-pituitary-adrenal (HPA) axis reactivity. Psychoneuroendocrinology 2006; 31: 642-652.
53. Ochedalski T, Subburaju S, Wynn PC, Aguilera G. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity. J Neuroendocrinol 2007; 19: 189-197.
54. Seale JV, Wood SA, Atkinson HC, Harbuz MS, Lightman SL. Gonadal steroid replacement reverses gonadectomy-induced changes in the corticosterone pulse profile and stress-induced hypothalamic-pituitary-adrenal axis activity of male and female rats. J Neuroendocrinol 2004; 16: 989-998.
55. Lolait SJ, O'Carroll A-M, Mahan LC, Felder CC, Button DC, Young WS, Mezey E, Brownstein MJ. Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc Natl Acad Sci USA 1995; 92: 6783-6787.
56. Vaccari C, Lolait SJ, Ostrowski NL. Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain. Endocrinology 1998; 139: 5015-5033.
57. Hernando F, Schoots O, Lolait SJ, Burbach JP. Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin. Endocrinology 2001; 142: 1659-1668.
58. Young WS, Li J, Wersinger S, Palkovits M. The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy. Neuroscience 2006; 143: 1031-1039.